Epidemiology of hepatocellular carcinoma in the department of Calvados;Epidemiologie du carcinome hepatocellulaire dans le departement du Calvados

Gastroenterologie Clinique et Biologique

Volumn 21, Issue 6-7, 1997, Pages 450-458

  Even, Christian ^a   Launoy, Guy ^a   Collet, Thierry ^a   Duval, Olivier ^a   Piquet, Marie Astrid ^a   Rougereau, Annie ^a   Verwaerde, Jean Cluude ^a   Dao, Thông ^a  

^a CHU CÔTE DE NACRE   (France)

Author keywords

Alcohol; Cirrhosis; Epidemiology; Hepatocellular carcinoma; Prognosis

Indexed keywords

ADULT; AGE; AGED; ALCOHOL LIVER DISEASE; ARTICLE; CANCER INCIDENCE; CANCER SURVIVAL; FEMALE; HEPATITIS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; SEX RATIO; ALCOHOL LIVER CIRRHOSIS; FRANCE; LIVER TUMOR; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; REGISTER; REVIEW;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; FRANCE; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; REGISTRIES;

EID: 0030879726     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Rustgi VK. Epidemiology of hepatocellular carcinoma. Gastroenterol Clin North Am 1987;16:545-51.
2. Munoz N, Bosch X. Epidemiology of hepatocellular carcinoma. In: Okuda K, Ishak KG, eds. Neoplasms of the liver. Tokyo: Springer-Verlag, 1987:3-19.
3. Johnson PJ, Williams R. Cirrhosis and aetiology of hepatocellular carcinoma. J Hepatol 1987;4:140-7.
4. Colombo M. Hepatocellular carcinoma. J Hepatol 1992;15:225-36.
5. Boutron MC, Faivre J, Milan C, Bedenne L, Hillon P, Klepping C. Primary liver cancer in Côte-d'Or (France). Int J Epidemiol 1988;17:21-6.
6. Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Semin Liver Dis 1995;1:64-9.
7. Maringhini A, Cottone M, Sciarrino E, Marceno MP, La Seta F, Fusco G, et al. Ultrasonography and alpha-fetoprotein in diagnosis of hepatocellular carcinoma in cirrhosis. Dig Dis Sci 1988;33:47-51.
8. Launoy G, Grosclaude P, Pienkowski P, Faivre J, Menegoz F, Schaffer P, et al. Les cancers digestifs en France. Comparaison de l'incidence dans 7 départements et estimation de l'incidence pour la France entière. Gastroenterol Clin Biol 1992;16:633-8.
9. Jensen OM, Estève J, Moller H, Renard H. Cancer in the European community and its members states. Eur J Cancer 1990;26:1167-256.
10. Coppéré H, Audigier JC. Évolution de la mortalité par cirrhose en France entre 1925 et 1982. Gastroenterol Clin Biol 1986;10:468-74.
11. Zaman S, Johnson RD, Johnson PJ, Melia WM, Portmann BC, Williams R. Risks factors in development of hepatocellular carcinoma in cirrhosis: prospective study of 613 cases. Lancet 1985;15:1357-60.
12. Poynard T, Aubert A, Lazizi Y, Bedossa P, Hamelin B, Terris B, et al. Independent risk factors for hepatocellular carcinoma in French drinkers. Hepatology 1991;13:896-901.
13. Tarao K, Ohkawa S, Shimizu A, Harada M, Nakamura Y, Ito Y, et al. The male preponderance in incidence of hepatocellular carcinoma in cirrhotic patients may depend on the higher DNA synthetic activity of cirrhotic tissue in men. Cancer 1993;72:369-74.
14. Dunk AA, Spiliadis H, Sherlock S, Fowler MJF, Monjardino JP, Scheuer PJ, et al. Hepatocellular carcinoma: clinical, aetiological and pathologic features in British patients. Int J Cancer 1988;41:17-23.
15. Sutton FM, Russel NC, Guinee VF, Alpert E. Factors affecting the prognosis of primary liver carcinoma. J Clin Oncol 1988;6:321-8.
16. Mels GC, Leandro G, Scorpiniti A, Cristini P, Moretti GB, Di Nolfo AM, et al. Epidemiology of hepatocellular carcinoma in a province of Northern Italy: prevalence of the risk factors and incidence in the population. Tumori 1993;1:16-21.
17. Beasley RP. Hepatitis B virus. The major etiology of hepatocellular carcinoma. Cancer 1988;61:1942-56.
18. Saracci R, Repetto F. Time trends of primary liver cancer: indication of increased incidence in selected cancer registry population. J Natl Cancer Inst 1980;65:241-7.
19. Okuda K, Fujimoto J, Hanai A, Urano Y. Changing incidence in hepatocellular carcinoma in Japan. Cancer Res 1987;47:4967-72.
20. Van Resburg SJ, Cook-Mazaffari P, Van Schalwik DJ, Van der Watt JJ, Vincent TJ, Purchase IF. Hepatocellular carcinoma and dietary aflatoxin in Mozambic and Transkei. BrJ Cancer 1985; 51:713-26.
21. Bradshaw E, Mac Glashand ND, Fitzgerald D, Harington JS. Analyses of cancer incidence in black gold miners from Southern Africa (1964-79). Br J Cancer 1982;46:737-48.
22. Darnis F. Problèmes étiologiques actuels posés, en France, par le cancer primitif du foie développé sur cirrhose. Bull Acad Natl Med 1991;175:547-57.
23. Lelbach WK. Cirrhosis in the alcoholic and its relation to the volume of alcohol abuse. Ann N Y Acad Sci 1975;252:85-105.
24. Adami HO, Hsing AW, McLaughlin JK, Trichopoulos D, Hacker D, Ekbom A, et al. Alcoholism and liver cirrhosis in the etiology of primary liver cancer. Int J Cancer 1992;51:898-902.
25. Tiribelli C, Melato M, Croce LS, Giarelli L, Okuda K, Ohnishi K. Prevalence of hepatocellular carcinoma and relation to cirrhosis: comparison of two different cities of the world, Trieste, Italy and Chiba, Japan. Hepatology 1989;79:998-1002.
26. Ruiz J, Sangro B, Cuende JI, Beloqui O, Riezu-Boj JI, Herrero JI, et al. Hepatitis B and C viral infections in patients with hepatocellular carcinoma. Hepatology 1992;16:637-41.
27. Peters M, Wellek S, Dienes HP, Junginger T, Meyer J, Meyer KH, et al. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C. Z Gastroenterol 1994;32:146-51.
28. Attali P, Thibault N, Buffet C, Briantais MJ, Papoz L, Chaput JC, et al. Les marqueurs du virus B chez les alcooliques chroniques. Gastroenterol Clin Biol 1981;5:1095-102.
29. Nalpas B, Driss F, Pol S, Hamelin B, Housset C, Bréchot C, et al. Association between HCV and HBV infection in hepatocellular carcinoma and alcoholic liver disease. J Hepatol 1991;12:70-4.
30. Attali P, Prod'homme S, Pelletier G, Papoz L, Buffet C, Etienne JP. Carcinomes hépatocellulaires en France. Aspects cliniques, biologiques et virologiques chez 197 malades. Gastroenterol Clin Biol 1985;9:396-402.
31. Bertrand L, Brunin JL, Blanc F. Le cancer primitif du foie chez l'Européen. Étude monocentrique sur 230 cas. Sem Hop Paris 1987;63:1383-9.
32. Ducreux M, Buffet C, Dussaix EA, Pelletier G, Briantais MJ, Yvart J. Antibody to hepatitis C in hepatocellular carcinoma. Lancet 1990;1:300-1.
33. Zarski JP, Lunel F, Dardelet D, Thelu MA, Baccard M, Perrin M, et al. Hepatitis C virus and hepatocellular carcinoma in France: detection of antibodies using two second generation assays. J Hepatol 1991;13:376-7.
34. Thelu MA, Zarski JP, Dardelet D, Lunel F, Seigneurin JM. Low prevalence of hepatitis C virus genome detected by PCR serum of Caucasian patients with hepatocellular carcinoma. J Hepatol 1992;14:415-6.
35. Takano S, Yokosuka O, Imazeki F, Tagawa M, Omata M. Incidence of hepatocellular carcinoma in chronic hepatitis B and C: a prospective study of 251 patients. Hepatology 1995;21:650-5.
36. Nousbaum JB, Pol S, Nalpas B, Landais P, Berthelot P, Bréchot C, et al. Hepatitis C virus type 1b infection in France and Italy. Ann Intern Med 1995;122:161-8.
37. Nalpas B. Alcool et virus de l'hépatite C: le retour des virus hépatotropes. Gastroenterol Clin Biol 1994;18:105-9.
38. Bréchot C, Degos F, Lugassy C, Thiers V, Zafrani S, Franco D, et al. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 1985;312:270-6.
39. Paterlini P, Gerken G, Nakajima E, Terre S, D'Errico A, Grigioni W, et al. Polymerase chain reaction to detect hepatitis B virus DNA and RNA sequences in primary liver cancer from patients negative for hepatitis B surface antigen. N Engl J Med 1990;323:80-5.
40. Walter E, Blum HE, Meier P, Huonker M, Schmid M, Paier KP, et al. Hepatocellular carcinoma in alcoholic liver: no evidence for a pathogenic role of hepatitis B virus infection. Hepatology 1988;8:745-8.
41. Imazeki F, Omata M, Yokosuka O, Okuda K. Integration of hepatitis B virus DNA in hepatocellular carcinoma. Cancer 1986;58:1055-60.
42. Smalley SR, Moertel CG, Hilton JF, Weiland LH, Wieand HS, Adson MA, et al. Hepatoma in the non-cirrhotic liver. Cancer 1988;62:1414-24.
43. Okuda K, Nakashima T, Masamichi K, Kondo Y, Wada K. Hepatocellular carcinoma without cirrhosis in japanese patients. Gastroenterology 1989;97:140-6.
44. Trevisani F, D'Intino PE, Caraceni P, Pizzo M, Stefanini GF, Maziotti A, et al. Etiologic factors and clinical presentation of hepalocellular carcinoma. Differences between cirrhotic and non cirrhotic patients. Cancer 1995;75:2220-32.
45. Pateron D, Ganne N, Trinchet JC, Aurousseau MH, Mal F, Meicler C, et al. Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis. J Hepatol 1994;20:65-71.
46. Colombo M, De Franchis R, Del Ninno E, Sangiovanni A, De Fazio C, Tommasini M, et al. Hepatocellular carcinoma in Italian patients with cirrhosis. N Engl J Med 1985;325:675-80.
47. Falkson G, Cnaan A, Schutt AJ, Ryan AM, Falkson HC. Prognostic factors for survival in hepatocellular carcinoma. Cancer Res 1988;48:7314-8.
48. Okuda K, Ohtsuki T, Obata H, Tomimatsu M, Okazaki N, Hasegawa H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients. Cancer 1985;56:918-28.
49. Calvet X, Bruix J, Gines P, Bru C, Sole M, Vilana R, et al. Prognostic factors of hepatocellular carcinoma in the West: a multivariate analysis in 206 patients. Hepatology 1990;12:753-60.
50. Rosselini S, Arienti V, Nanni O, Ugenti F, Tassinari M, Camporesi C, et al. Hepatocellular carcinoma: prognostic factors and survival analysis in 135 Italian patients. J Hepatol 1992;16:66-72.
51. Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival. Hepatology 1992;16:132-7.
52. Nomura F, Ohnishi K, Tanabe Y. Clinical features and prognosis of hepatocellular carcinoma with reference to serum alpha-fetoprotein levels: analysis of 606 patients. Cancer 1989;64:1700-7.
53. Matsumoto Y, Suzuki T, Asada I, Ozawa K, Tobe T, Honjo I. Clinical classification of hepatoma in Japan according to serial changes in serum alpha-fetoprotein levels. Cancer 1982;49:354-60.